And guys would benefit from paying attention to their skin cancer risk. “The truth is that, in aggregate, men just don’t take ...

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

Douglas Adkins, MD, discusses future directions of the KEYNOTE-689 trial of pembrolizumab in head and neck cancer following the agent's FDA approval.

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.

Globally, women are roughly twice as likely as men to be diagnosed with thyroid cancer. However, recent research shows that ...